Natural decline of (extra) pulmonary features in patients with COPD: a slippery slope

L. Vanfleteren (Gothenburg, Sweden)

Source: Virtual Congress 2021 – Maintenance of the beneficial effects of pulmonary rehabilitation: the role of digital health

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Vanfleteren (Gothenburg, Sweden). Natural decline of (extra) pulmonary features in patients with COPD: a slippery slope. Virtual Congress 2021 – Maintenance of the beneficial effects of pulmonary rehabilitation: the role of digital health

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Response to pulmonary rehabilitation (PR) in bronchiectasis and COPD: a propensity matched analysis
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2017



Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Late Breaking Abstract - Change in airway volume, measured with functional respiratory imaging (FRI), differentiates between stable and progressive idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


The relationship between echodensitometric parameters of respiratory muscles (RM) and indices of body composition (IBC) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011


Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008


Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Clinical case on COPD: an unexpectedly long story with an unforeseen end
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007

Effects of pulmonary rehabilitation (PR) on arterial stiffness in patients with COPD: The CIROCO study
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011

Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation?
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017


6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013

Chest wall volumes during constant compared to incremental cycle ergometer tests in chronic obstructive pulmonary disease (COPD) patients: A systematic review and meta-analysis
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015